MONETA, CLAUDIA
MONETA, CLAUDIA
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.004 secondi).
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.
2023 S. De Leo, M. Trevisan, C. Moneta, C. Colombo
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
2023 S. De Leo, M. Trevisan, C. Colombo, C. Moneta, N. Giancola, L. Fugazzola
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
2022 M. Trevisan, C. Colombo, N. Giancola, C. Moneta, G. Dionigi, L. Fugazzola, S. De Leo
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors. | 1-mag-2023 | De Leo SMoneta CColombo C. + | Article (author) | - | |
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting | 1-gen-2023 | Trevisan, MatteoColombo, CarlaMoneta, ClaudiaGiancola, NoemiFugazzola, Laura + | Article (author) | - | |
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism | 1-ott-2022 | Trevisan M.Colombo C.Giancola N.Moneta C.Dionigi G.Fugazzola L. + | Article (author) | - | |
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm | 1-gen-2023 | Carla ColomboDaniele CerutiSimone De LeoMatteo TrevisanNoemi GiancolaClaudia MonetaLuca PersaniLaura Fugazzola + | Article (author) | - |